EU grants BioNTech-Pfizer XFG-targeted COVID shot approval for 2026-27 season
Reuters2026/07/29 20:56- European Commission granted EU marketing authorization for Pfizer-BioNTech’s XFG-adapted monovalent COVID-19 vaccine for the 2026-2027 season.
- Authorization covers active immunization from 6 months of age across the EU, Iceland, Liechtenstein, Norway.
- Companies started manufacturing at risk; shipments set to begin shortly to support seasonal rollout.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Storage Giant Offers Huge Bonuses Again: Micron Awards Up to 68 Months’ Bonus
Micron Technology has announced record-breaking bonuses for its employees in Taiwan, ranging from 35 to 68 months’ salary, with a minimum cash compensation of 1.7 million New Taiwan dollars. However, the Taoyuan union, representing about two-thirds of Micron’s workers in Taiwan, has refused to accept the offer, insisting that 15% of operating profits be included in the bonus distribution and maintaining the threat of a strike.
Dogecoin ETF Closure Sets October Exit for Bitwise BWOW Holders
Crypto prices
More
